MBOT (STOCKS)
Microbot Medical, Inc. Common Stock
$2.370000
-0.220000 (-8.49%)
Prev close: $2.590000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Harel Gadot
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $158.16M
- Employees
- 22
- P/E (TTM)
- -8.48
- P/B (TTM)
- 2.24
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
6
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.04 | $-0.06 | +0.0212 | +34.64% |
|
Sep 2025 (Q3)
|
$-0.07 | $-0.06 | -0.0088 | -14.38% |
|
Jun 2025 (Q2)
|
$-0.10 | $-0.08 | -0.0184 | -22.55% |
|
Mar 2025 (Q1)
|
$-0.09 | $-0.13 | +0.0426 | +32.13% |
Financial Statements
| Selling, General, and Administrative Expenses | $8.46M |
| Research and Development | $6.28M |
| Operating Income/Loss | -$14.74M |
| Income/Loss From Continuing Operations After Tax | -$13.14M |
| Income/Loss From Continuing Operations Before Tax | -$13.14M |
| Net Income/Loss | -$13.14M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$13.14M |
| Net Income/Loss Available To Common Stockholders, Basic | -$13.14M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.29 |
| Diluted Earnings Per Share | -$0.29 |
| Basic Average Shares | 45,790,362 |
| Diluted Average Shares | 45,790,362 |
| Assets | $81.54M |
| Current Assets | $79.82M |
| Cash | $78.59M |
| Prepaid Expenses | $403.00K |
| Other Current Assets | $827.00K |
| Noncurrent Assets | $1.72M |
| Fixed Assets | $93.00K |
| Other Non-current Assets | $1.63M |
| Liabilities | $3.99M |
| Current Liabilities | $3.42M |
| Accounts Payable | $511.00K |
| Wages | $1.98M |
| Other Current Liabilities | $931.00K |
| Noncurrent Liabilities | $569.00K |
| Equity | $77.55M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $77.55M |
| Liabilities And Equity | $81.54M |
| Net Cash Flow From Operating Activities | -$13.05M |
| Net Cash Flow From Operating Activities, Continuing | -$13.05M |
| Net Cash Flow From Investing Activities | -$72.38M |
| Net Cash Flow From Investing Activities, Continuing | -$72.38M |
| Net Cash Flow From Financing Activities | $86.24M |
| Net Cash Flow From Financing Activities, Continuing | $86.24M |
| Net Cash Flow | $810.00K |
| Net Cash Flow, Continuing | $810.00K |
| Comprehensive Income/Loss | -$13.14M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$13.14M |
| Other Comprehensive Income/Loss | $0.00 |